LIFECORE BIOMEDICAL INC(LFCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LFCR LIFECORE BIOMEDICAL INC

交易中 04-10 12:19:45 EDT

4.76

+0.04

+0.85%

最高4.78	最低4.61	成交量18.91万
今开4.71	昨收4.72	日振幅3.50%
总市值1.78亿	流通市值9,056万	总股本3,747万
成交额88.78万	换手率0.99%	流通股本1,902万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LFCR","market":"US","secType":"STK","nameCN":"LIFECORE BIOMEDICAL INC","latestPrice":4.76,"timestamp":1775837981881,"preClose":4.72,"halted":0,"volume":189099,"delay":0,"changeRate":0.00847457627118645,"floatShares":19024455,"shares":37466352,"eps":-0.925714,"marketStatus":"交易中","change":0.04,"latestTime":"04-10 12:19:45 EDT","open":4.71,"high":4.775,"low":4.61,"amount":887847.5269134,"amplitude":0.034958,"askPrice":4.77,"askSize":1251,"bidPrice":4.75,"bidSize":185,"shortable":3,"etf":0,"ttmEps":-0.925714,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1775851200000},"marketStatusCode":2,"adr":0,"listingDate":824274000000,"exchange":"NASDAQ","adjPreClose":4.72,"preHourTrading":{"tag":"盘前","latestPrice":4.84,"preClose":4.72,"latestTime":"09:29 EDT","volume":1863,"amount":8971.42554,"timestamp":1775827777361,"change":0.12,"changeRate":0.025424,"amplitude":0.038136},"postHourTrading":{"tag":"盘后","latestPrice":4.88,"preClose":4.72,"latestTime":"19:30 EDT","volume":5248,"amount":24931.5253,"timestamp":1775777421466,"change":0.16,"changeRate":0.033898,"amplitude":0.033898},"volumeRatio":0.84737,"impliedVol":0.1394,"impliedVolPercentile":0.016},"requestUrl":"/m/hq/s/LFCR","defaultTab":"news","newsList":[{"id":"1165892177","title":"Lifecore Biomedical与Indomo签署新协议，共同推动创新型药物器械组合痤疮疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1165892177","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165892177?lang=zh_cn&edition=full","pubTime":"2026-03-05 05:04","pubTimestamp":1772658253,"startTime":"0","endTime":"0","summary":"LifECORE BIOMEDICAL INC（简称Lifecore）近日宣布与Indomo达成一项全新合作协议，旨在支持开发一种结合药物与器械的创新性痤疮治疗方案。此次合作将整合双方在生物材料与医疗器械领域的专长，有望为痤疮患者提供更高效、便捷的治疗选择。\n该药物器械组合疗法预计将利用Lifecore在生物医药材料方面的技术积累，结合Indomo在设备设计上的创新能力，打造差异化的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","LFCR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184255114","title":"Lifecore Biomedical与新大型跨国制药客户签署CDMO主服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1184255114","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184255114?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:06","pubTimestamp":1765973168,"startTime":"0","endTime":"0","summary":"Lifecore Biomedical与新大型跨国制药客户签署CDMO主服务协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFCR","BK4121","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189952474","title":"Lifecore Biomedical将注射药品的商业生产从当前制造商转移到公司设施","url":"https://stock-news.laohu8.com/highlight/detail?id=1189952474","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189952474?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:27","pubTimestamp":1761737255,"startTime":"0","endTime":"0","summary":"Lifecore Biomedical将注射药品的商业生产从当前制造商转移到公司设施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","LFCR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108684378","title":"Lifecore与Polypeptide宣布合作，旨在为美国市场提供全面的肽生产解决方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1108684378","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108684378?lang=zh_cn&edition=full","pubTime":"2025-10-28 19:02","pubTimestamp":1761649361,"startTime":"0","endTime":"0","summary":"Lifecore与Polypeptide宣布合作，旨在为美国市场提供全面的肽生产解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","LFCR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575404910","title":"Lifecore Biomedical, Inc.盘中异动 早盘股价大涨7.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575404910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575404910?lang=zh_cn&edition=full","pubTime":"2025-10-13 21:30","pubTimestamp":1760362229,"startTime":"0","endTime":"0","summary":"北京时间2025年10月13日21时30分，Lifecore Biomedical, Inc.股票出现异动，股价大幅上涨7.84%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.00%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc 是一家完全集成的合同开发和制造组织 ，提供注射器、西林瓶和药筒等复杂无菌注射剂产品的开发、灌装和成品服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013213029a6b7306b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013213029a6b7306b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4212","CDMO","BK4139","LFCR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514090138","title":"Lifecore Biomedical, Inc.盘中异动 急速拉升6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090138?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:37","pubTimestamp":1740494269,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时37分，Lifecore Biomedical, Inc.股票出现波动，股价大幅上涨6.43%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为1.46%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522374998924e1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522374998924e1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4121","BK4212","CDMO","LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506568588","title":"Lifecore Biomedical, Inc.盘中异动 股价大跌5.06%报6.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506568588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506568588?lang=zh_cn&edition=full","pubTime":"2025-01-28 01:27","pubTimestamp":1737998821,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日01时27分，Lifecore Biomedical, Inc.股票出现异动，股价快速下跌5.06%。截至发稿，该股报6.00美元/股，成交量3.105万股，换手率0.08%，振幅5.06%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为2.25%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128012701a2318e47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128012701a2318e47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4121","BK4212","TKNO","LFCR","BK4139","CDMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505432023","title":"Lifecore Biomedical, Inc.盘中异动 股价大跌5.13%报6.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505432023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505432023?lang=zh_cn&edition=full","pubTime":"2025-01-24 04:22","pubTimestamp":1737663720,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时22分，Lifecore Biomedical, Inc.股票出现波动，股价快速下挫5.13%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.69%。其相关个股中，Cbdmd, Inc.、阿玛琳、Eton Pharmaceuticals, Inc.涨幅较大，Cbdmd, Inc.、Inmed Pharmaceuticals Inc.、Painreform Ltd.较为活跃，换手率分别为48.53%、34.22%、19.86%，振幅较大的相关个股有Cbdmd, Inc.、Petros Pharmaceuticals, Inc.、Gelteq Limited，振幅分别为26.13%、19.84%、18.55%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124042200a22d4db6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124042200a22d4db6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","LFCR","BK4121","BK4212","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502862870","title":"Lifecore Biomedical, Inc.盘中异动 股价大涨5.00%报6.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502862870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502862870?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:32","pubTimestamp":1736519537,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时32分，Lifecore Biomedical, Inc.股票出现异动，股价快速拉升5.00%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.10%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223217aba602bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223217aba602bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LFCR","BK4212","BK4121","BK4139","CDMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501778863","title":"Lifecore Biomedical, Inc.盘中异动 大幅下挫5.82%报6.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501778863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501778863?lang=zh_cn&edition=full","pubTime":"2025-01-07 22:42","pubTimestamp":1736260959,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时42分，Lifecore Biomedical, Inc.股票出现异动，股价大幅下挫5.82%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.23%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107224239aba1e1dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107224239aba1e1dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","LFCR","BK4212","BK4007","CDMO","PTPI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501129643","title":"Lifecore Biomedical（LFCR.O）：2025年Q2营收3260万美元，净亏损660万美元，实施增长战略，产能翻倍至3亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501129643","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501129643?lang=zh_cn&edition=full","pubTime":"2025-01-07 06:41","pubTimestamp":1736203260,"startTime":"0","endTime":"0","summary":"01. Lifecore Biomedical（LFCR.O）业绩电话会：2025年Q2，公司营收3260万美元，同比增长8%，毛利润1110万美元，增加110万美元。销售管理费用1110万美元，净亏损660万美元。上半年营收5730万美元，增长5%，毛利润1650万美元，增加380万美元。净亏损2280万美元。公司实施增长战略，目标12%营收复合年增长，EBITDA利润率超25%。业务开发管道增长，与大型跨国公司合作增多。产能翻倍至3亿美元，任命新高管以降低成本、保持品质。毛利率预计全年约30%，债务约1.6亿美元。\n\n\n\n\n\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-07/doc-ineeautf2488693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501256265","title":"Lifecore Biomedical, Inc.盘中异动 早盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501256265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501256265?lang=zh_cn&edition=full","pubTime":"2025-01-06 23:11","pubTimestamp":1736176315,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日23时11分，Lifecore Biomedical, Inc.股票出现波动，股价快速下挫5.25%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.30%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106231156985cef7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106231156985cef7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4121","LFCR","BK4212","CDMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501244089","title":"Lifecore Biomedical（LFCR.O）：2025年Q2营收3260万美元，同比增长8%，完成股票发行增强流动性","url":"https://stock-news.laohu8.com/highlight/detail?id=2501244089","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501244089?lang=zh_cn&edition=full","pubTime":"2025-01-06 06:41","pubTimestamp":1736116860,"startTime":"0","endTime":"0","summary":"01. Lifecore Biomedical（LFCR.O）业绩电话会：2025年Q2，公司营收3260万美元，同比增长8%，毛利润1110万美元，增加110万美元，净亏损660万美元。上半年营收增长5%，毛利润增加380万美元，净亏损2280万美元。完成2430万美元股票发行，增强流动性。公司增长战略目标为12%营收复合年增长率，EBITDA利润率超25%。业务渠道增长，特别是大型跨国公司业务，占渠道的30%以上。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-06/doc-inecyrue8813194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500111248","title":"Lifecore Biomedical, Inc.盘中异动 股价大涨6.46%报7.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500111248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500111248?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:31","pubTimestamp":1735914665,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时31分，Lifecore Biomedical, Inc.股票出现波动，股价快速拉升6.46%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.00%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Therapeuticsmd, Inc.、Cbdmd, Inc.涨幅较大，Painreform Ltd.、Therapeuticsmd, Inc.、Cbdmd, Inc.较为活跃，换手率分别为6.13%、5.43%、5.41%，振幅较大的相关个股有Therapeuticsmd, Inc.、Cbdmd, Inc.、Lifecore Biomedical, Inc.，振幅分别为9.03%、5.31%、4.80%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223105a2146897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223105a2146897&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4139","CDMO","BK4212","LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500907359","title":"Lifecore Biomedical(LFCR.US)：2025年Q2财报实现营收3256.4万美元，前值为3015万美元，预期值为2975万美元；每股收益为-0.25美元，前值为0.39美元，预期值为-0.31美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2500907359","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500907359?lang=zh_cn&edition=full","pubTime":"2025-01-03 05:23","pubTimestamp":1735853025,"startTime":"0","endTime":"0","summary":"Lifecore Biomedical(LFCR.US)：2025年Q2财报实现营收3256.4万美元，前值为3015万美元，预期值为2975万美元；每股收益为-0.25美元，前值为0.39美元，预期值为-0.31美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/03052347069557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129087770","title":"Lifecore Biomedical 2025年第二季度GAAP每股收益$(0.25)优于预期$(0.29)，销售额$3260万高于预期$2975万","url":"https://stock-news.laohu8.com/highlight/detail?id=1129087770","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129087770?lang=zh_cn&edition=full","pubTime":"2025-01-03 05:08","pubTimestamp":1735852100,"startTime":"0","endTime":"0","summary":"Lifecore Biomedical 报告季度每股亏损$，优于分析师普遍预期的$，差异率为13.79%。公司报告季度销售额为$3260万，超过分析师普遍预期的$2975万，差异率为9.59%。与去年同期的$3015万相比，这一销售额增长了8.13%。以上内容来自Benzinga Earnings专栏，原文如下：Lifecore Biomedical  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 13.79 percent.  The company reported quarterly sales of $32.60 million which beat the analyst consensus estimate of $29.75 million by 9.59 percent.  This is a 8.13 percent increase over sales of $30.15 million the same period last ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lifecore Biomedical 2025年第二季度GAAP每股收益$(0.25)优于预期$(0.29)，销售额$3260万高于预期$2975万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500920062","title":"Lifecore Biomedical, Inc.盘中异动 早盘股价大跌5.25%报7.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500920062","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500920062?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:08","pubTimestamp":1735830508,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日23时08分，Lifecore Biomedical, Inc.股票出现波动，股价大幅下挫5.25%。截至发稿，该股报7.04美元/股，成交量5.0757万股，换手率0.14%，振幅4.71%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为1.18%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102230828a2130aa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102230828a2130aa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4121","LFCR","BK4212","CDMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494355503","title":"Lifecore Biomedical, Inc.盘中异动 急速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494355503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494355503?lang=zh_cn&edition=full","pubTime":"2024-12-28 01:46","pubTimestamp":1735321593,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日01时46分，Lifecore Biomedical, Inc.股票出现波动，股价快速下挫5.01%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.99%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412280146349851fb12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412280146349851fb12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","BK4139","BK4121","BK4212","LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493853038","title":"Lifecore Biomedical, Inc.盘中异动 股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493853038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493853038?lang=zh_cn&edition=full","pubTime":"2024-12-24 23:04","pubTimestamp":1735052645,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日23时04分，Lifecore Biomedical, Inc.股票出现波动，股价急速拉升5.41%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.69%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224230405984d8afc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224230405984d8afc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CDMO","LFCR","BK4121","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492159465","title":"Lifecore Biomedical, Inc.盘中异动 临近收盘快速跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492159465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492159465?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:38","pubTimestamp":1734554293,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时38分，Lifecore Biomedical, Inc.股票出现波动，股价大幅下挫5.15%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为1.41%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043813ab829f9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043813ab829f9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","BK4121","LFCR","BK4139","BK4212"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lifecore.com","stockEarnings":[{"period":"1week","weight":0.2292},{"period":"1month","weight":-0.3159},{"period":"3month","weight":-0.3757},{"period":"6month","weight":-0.2738},{"period":"1year","weight":-0.2424},{"period":"ytd","weight":-0.423}],"compareEarnings":[{"period":"1week","weight":0.0367},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0204},{"period":"6month","weight":0.0412},{"period":"1year","weight":0.2393},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lifecore Biomedical, Inc.于1986年10月31日在加利福尼亚州注册成立，并于2008年11月6日重新注册为特拉华州公司。该公司及其子公司为食品和生物材料市场设计、开发、制造和销售差异化产品，并向合作伙伴许可技术应用。该公司已发展成为美国领先的药用级非动物源透明质酸 (HA) 生产商，采用其于1981年开发的专有发酵工艺。Lifecore生产散装透明质酸，以及用于配制和灌装注射剂的注射器和安瓿瓶，这些注射剂可用于治疗包括眼科和骨科在内的多种疾病。此外，Lifecore还运用其在HA生产方面的专业知识，与客户合作，为各种应用创造了高粘度非HA基无菌注射产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.433333,"avgChangeRate":0.014109},{"month":2,"riseRate":0.433333,"avgChangeRate":-0.008997},{"month":3,"riseRate":0.612903,"avgChangeRate":0.010835},{"month":4,"riseRate":0.516129,"avgChangeRate":0.019217},{"month":5,"riseRate":0.7,"avgChangeRate":0.050222},{"month":6,"riseRate":0.5,"avgChangeRate":0.004019},{"month":7,"riseRate":0.366667,"avgChangeRate":-0.009675},{"month":8,"riseRate":0.5,"avgChangeRate":-0.000145},{"month":9,"riseRate":0.4,"avgChangeRate":0.003998},{"month":10,"riseRate":0.366667,"avgChangeRate":-0.007015},{"month":11,"riseRate":0.5,"avgChangeRate":0.007022},{"month":12,"riseRate":0.533333,"avgChangeRate":0.010193}],"exchange":"NASDAQ","name":"LIFECORE BIOMEDICAL INC","nameEN":"LIFECORE BIOMEDICAL INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LIFECORE BIOMEDICAL INC(LFCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供LIFECORE BIOMEDICAL INC(LFCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"LIFECORE BIOMEDICAL INC,LFCR,LIFECORE BIOMEDICAL INC股票,LIFECORE BIOMEDICAL INC股票老虎,LIFECORE BIOMEDICAL INC股票老虎国际,LIFECORE BIOMEDICAL INC行情,LIFECORE BIOMEDICAL INC股票行情,LIFECORE BIOMEDICAL INC股价,LIFECORE BIOMEDICAL INC股市,LIFECORE BIOMEDICAL INC股票价格,LIFECORE BIOMEDICAL INC股票交易,LIFECORE BIOMEDICAL INC股票购买,LIFECORE BIOMEDICAL INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LIFECORE BIOMEDICAL INC(LFCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供LIFECORE BIOMEDICAL INC(LFCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}